Cytokine therapy in the complex treatment of benign mechanical jaundice

The article analyzes the results of a comprehensive examination and treatment of 86 patients with benign mechanical jaundice. Inclusion in the complex of postdecompressive pathogenetically substantiated drug therapy roikoleukina in patients with benign mechanical jaundice can reduce the incidence of postoperative complications from 12.8 to 4.3% and significantly improve the results of surgical treatment.